NO983220L - Sammensetninger og fremgangsmåter for å administrere Borrelia Burgdorferi-antigener - Google Patents

Sammensetninger og fremgangsmåter for å administrere Borrelia Burgdorferi-antigener

Info

Publication number
NO983220L
NO983220L NO983220A NO983220A NO983220L NO 983220 L NO983220 L NO 983220L NO 983220 A NO983220 A NO 983220A NO 983220 A NO983220 A NO 983220A NO 983220 L NO983220 L NO 983220L
Authority
NO
Norway
Prior art keywords
compositions
methods
borrelia burgdorferi
burgdorferi antigens
administering
Prior art date
Application number
NO983220A
Other languages
English (en)
Other versions
NO983220D0 (no
Inventor
Alan G Barbour
Catherine J Luke
Original Assignee
Univ Texas System The
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK590288A external-priority patent/DK590288D0/da
Application filed by Univ Texas System The filed Critical Univ Texas System The
Publication of NO983220D0 publication Critical patent/NO983220D0/no
Publication of NO983220L publication Critical patent/NO983220L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
NO983220A 1988-10-24 1998-07-13 Sammensetninger og fremgangsmåter for å administrere Borrelia Burgdorferi-antigener NO983220L (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DK590288A DK590288D0 (da) 1988-10-24 1988-10-24 Kemiske forbindelser
US42288189A 1989-10-18 1989-10-18
US92479892A 1992-08-06 1992-08-06
US08/079,601 US5523089A (en) 1988-10-24 1993-06-22 Borrelia antigen
US08/588,637 US7094391B1 (en) 1988-10-24 1996-01-19 Compositions and methods for administering Borrelia burgdorferi antigens
PCT/US1997/000557 WO1997026006A1 (en) 1988-10-24 1997-01-17 Compositions and methods for administering borrelia burgdorferi antigens

Publications (2)

Publication Number Publication Date
NO983220D0 NO983220D0 (no) 1998-07-13
NO983220L true NO983220L (no) 1998-09-14

Family

ID=36821664

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983220A NO983220L (no) 1988-10-24 1998-07-13 Sammensetninger og fremgangsmåter for å administrere Borrelia Burgdorferi-antigener

Country Status (8)

Country Link
US (1) US7094391B1 (no)
EP (1) EP0876156A4 (no)
JP (1) JP2000507209A (no)
AU (1) AU740048B2 (no)
FI (1) FI981624A (no)
NO (1) NO983220L (no)
WO (1) WO1997026006A1 (no)
ZA (1) ZA97459B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007318026B2 (en) * 2006-11-03 2013-04-18 Merck Sharp & Dohme (Holdings) Pty Ltd Canine Lyme disease vaccine
ATE496935T1 (de) * 2007-02-22 2011-02-15 Baxter Int Verfahren zur aufreinigung hydrophober proteine
WO2011143617A1 (en) 2010-05-14 2011-11-17 Baxter International Inc. Chimeric ospa genes, proteins, and methods of use thereof
EP2877206B1 (en) 2012-07-27 2019-11-27 Baxalta GmbH Compositions comprising chimeric ospa molecules and methods of use thereof
WO2016193370A1 (en) * 2015-06-02 2016-12-08 De Staat Der Nederlanden, Vert. Door De Minister Van Vws, Ministerie Van Volksgezondheid, Welzijn En Sport Surface display of antigens on gram-negative outer membrane vesicles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) * 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
GB1596653A (en) * 1977-01-26 1981-08-26 Gist Brocades Nv Vaccine
IT1223777B (it) * 1988-08-18 1990-09-29 Gevipi Ag Rubinetto a due uscite con inversore a depressione
DE4015911A1 (de) * 1989-09-19 1991-03-28 Max Planck Gesellschaft Impfstoff gegen die lyme-krankheit
CA2084413A1 (en) * 1990-06-15 1991-12-16 Richard A. Flavell Compositions and methods for the prevention and diagnosis of lyme disease

Also Published As

Publication number Publication date
EP0876156A4 (en) 2004-09-08
NO983220D0 (no) 1998-07-13
FI981624A0 (fi) 1998-07-16
ZA97459B (en) 1997-08-04
AU740048B2 (en) 2001-10-25
EP0876156A1 (en) 1998-11-11
WO1997026006A1 (en) 1997-07-24
JP2000507209A (ja) 2000-06-13
AU1747097A (en) 1997-08-11
US7094391B1 (en) 2006-08-22
FI981624A (fi) 1998-08-05

Similar Documents

Publication Publication Date Title
NO941929L (no) Tokotrienoler og tokotrienol-lignende sammensetninger og fremgangsmåter for deres anvendelse
DK0412486T3 (da) Antistoffer mod TNF-bindingsprotein I og F(ab)-fragmenter
DK527789D0 (da) Dithiocarbamoylquinoloner og sammensaetninger omfattende samme
AU1453488A (en) Novel compositions for therapeutic percutaneous embolization and the use thereof
HK1094148A1 (en) Synergistic therapeutic compositions and methods
FI891286A (fi) Hammaskiveä ehkäisevä oraalinen koostumus
NO954612L (no) Metoder og preparater for å behandle ooforektomiserte kvinner
TR25923A (tr) Deterjan terkipleri ve bunlari hazirlamaya mahsus usul
BR8905204A (pt) Composicao colutoria
IT1232831B (it) Adsorbati di resina, procedimento per prepararli e composizioni farmaceutiche che li contengono
DK451388D0 (da) Terapeutisk nucleosider og farmaceutiske kompositioner indeholdende forbindelserne
DE68912237D1 (de) Dampfsensitive Zusammensetzung sowie diese enthaltende sterilisierungsanzeigende Zusammensetzung.
DE69031902D1 (de) Durch Bestrahlung härtbare Organosiloxangelzusammensetzungen
BR8902338A (pt) Composicao oral
MX164890B (es) Composicion de resina aglutinante extruible
NO893196D0 (no) Hybrid-protein-c-sammensetninger og fremgangsmaater for deres fremstilling.
BR8903994A (pt) Composicao oral
NO983220L (no) Sammensetninger og fremgangsmåter for å administrere Borrelia Burgdorferi-antigener
HUT65838A (en) Pharmateutical preparations containing tnf inhibitors
NO893892L (no) Antimikrobiologisk sammensetning og fremgangsmaate for anvendelse.
BR8905444A (pt) Composicoes e aplicacao
BR8902491A (pt) Composicao
TR26099A (tr) Islah edilmis pestisid terkip
BR8907528A (pt) Composicao crio-protetora
NO885640D0 (no) Framgangsmaate og sammensetninger for katodisk beskyttelse.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application